4-chloro-N-(2-(2-(6-methoxyquinolin-4-yl)ethyl)-trans-1,3-dioxan-5-yl)benzamide

ID: ALA4781609

PubChem CID: 162664738

Max Phase: Preclinical

Molecular Formula: C23H23ClN2O4

Molecular Weight: 426.90

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2nccc(CC[C@H]3OC[C@H](NC(=O)c4ccc(Cl)cc4)CO3)c2c1

Standard InChI:  InChI=1S/C23H23ClN2O4/c1-28-19-7-8-21-20(12-19)15(10-11-25-21)4-9-22-29-13-18(14-30-22)26-23(27)16-2-5-17(24)6-3-16/h2-3,5-8,10-12,18,22H,4,9,13-14H2,1H3,(H,26,27)/t18-,22-

Standard InChI Key:  ZUZQMIMKRITPON-LBZQVFOQSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   19.9425  -12.0459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6563  -11.6324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6535  -10.8056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9407  -10.4003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2303  -11.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2326  -10.8110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5225  -10.4019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8138  -10.8095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8155  -11.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5220  -12.0440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1019  -10.4010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.9372   -9.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6473   -9.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3609   -9.5729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3597  -10.3931    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0692  -10.7986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7817  -10.3905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7802   -9.5682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0661   -9.1541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4896  -10.7987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.2013  -10.3898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9133  -10.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2009   -9.5685    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0997   -9.5838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9117  -11.6187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6229  -12.0268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3334  -11.6143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3283  -10.7893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6165  -10.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0429  -12.0198    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  2  0
  8 11  1  0
  4 12  1  0
 12 13  1  0
 14 13  1  1
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  6
 20 21  1  0
 21 22  1  0
 21 23  2  0
 11 24  1  0
 22 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 22  1  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4781609

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

gyrB DNA gyrase (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
parC Topoisomerase IV (350 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.90Molecular Weight (Monoisotopic): 426.1346AlogP: 4.00#Rotatable Bonds: 6
Polar Surface Area: 69.68Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.22CX LogP: 4.00CX LogD: 4.00
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: -0.60

References

1. Lu Y,Papa JL,Nolan S,English A,Seffernick JT,Shkolnikov N,Powell J,Lindert S,Wozniak DJ,Yalowich J,Mitton-Fry MJ.  (2020)  Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus.,  11  (12): [PMID:33335666] [10.1021/acsmedchemlett.0c00428]

Source